Roche Holding AG (OTCMKTS:RHHVF – Get Free Report)’s stock price shot up 4.4% on Thursday . The stock traded as high as $445.8640 and last traded at $441.7080. Approximately 180 shares were traded during trading, a decline of 99% from the average session volume of 12,650 shares. The stock had previously closed at $423.1575.
Roche Stock Up 4.4%
The firm has a fifty day moving average price of $438.99 and a 200 day moving average price of $419.06.
About Roche
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Further Reading
- Five stocks we like better than Roche
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
